Pharmafile Logo

Can tobacco companies really reinvent themselves as healthcare companies?

December 20, 2021 | healthcare, tobacco, vaping 

A surprising move by key player, Phillip Morris, has called attention to the start of a new era for the tobacco industry. But can tobacco companies reinvent themselves as healthcare companies?

Since smoking was linked to serious diseases such as lung cancer in the 1950s, health experts have been focused on influencing consumer behaviour to reduce the popularity of tobacco products.

The tobacco industry once worked hard to disrupt well founded science and maintain public credibility. Clever PR campaigns minimised nicotine’s health risks by comparing it to caffeine or coffee and marketing strategies put cigarettes in the hands of Hollywood’s most famous, successfully defining and exploiting consumer culture.

However, with the taxation of cigarettes, ban on advertising and increasing awareness of the ill-effects there has been a significant decrease in the number of smokers, making it one of the most positive developments in global health. Communications played a vital role in this development, changing conversations around smoking and encouraging smokers to quit.

Recently, comms campaigns have become more opportunistic with initiatives such as WHO’s #CommitToQuit – launched during the pandemic – leveraging social apps, such as WhatsApp and Facebook, with online challenges to create digital support communities.

Now, a surprising move by key player, Phillip Morris, has called attention to the start of a new era for the tobacco industry. Despite being a world-renowned cigarette and tobacco company and manufacturer of best seller, Marlboro, their recent controversial move towards a smoke-free future raises huge doubts about the future of the tobacco industry.

Their endeavours range from replacing cigarettes with smoke-free products, to establishing a non-profit research organisation aimed at reducing smoke related deaths and even entering into the medical device arena by taking over an inhaler company, Vectura.

However, their intentions are highly criticised and not free from controversy. More than 100 public health organisations including WHO have rejected collaboration with the foundation and the likes of CRUK have accused them of trying to promote their smoking alternatives, such as heated tobacco. Vectura has also been highly criticised for prioritising short-term financial gain above long-term stability and commitment to patients with lung disease.

Public health organisations are no doubt suspicious of Phillip Morris’ moves. Whereas to consumers their motives may not matter as much as the availability of new and exciting smoke-free products. With existing health controversies surrounding smoking and vaping, it will be interesting to see whether similar ‘quit vaping’ ads emerge as cigarettes become a distant memory.

But can Philip Morris really establish themselves as a healthcare company?

This content was provided by Say Communications

Company Details

 Latest Content from  Say Communications 

The 7 truths behind successful Healthcare influencer engagement programmes

Pharma companies need to be engaging DOLs in the same way as Key Opinion Leaders (KOLs). But how can companies ensure best practice DOL engagement? Here are Say’s recommended critical...

Say wins Communiqué Awards for corporate influencer campaign based on life hacks

SAY received the top recognition for the ‘Excellence in Corporate Communications’ and ‘Excellence in Engagement Through Social Media/Digital Channels – Under £50,000’ categories with our “Lift Up Your Everyday with...

The immunotherapy knowledge gap: keeping the patient at the heart of cancer treatment

Advances in cancer treatment are frequent, but how much do we actually understand about these new treatments?

Meeting the experts behind the story: How building a bicycle led to a revolution in respiratory health

Hear from Professor Wladyslaw Wygnanski, inventor of a revolutionary respiratory medical device called BiMOD.

How ‘Greenwashing’ accusations could delay the very changes its supporters demand

Are shouts of companies ‘greenwashing’ to provide a façade of environmental and ethical respectability causing more harm than good? Or should we call out practices that we believe are papering...

The power of influence in transforming women’s health

Over the past four years HRT prescriptions have doubled in the UK, the cause was turbo charged by the action of celebrities and influencers.

The doctor will text you now: Why healthcare providers cannot underestimate the importance of communicating change

Healthcare communication needs to switch from ‘transmit’ to ‘receive’, listening to what patients need and embracing the plethora of communication tools wholeheartedly.

Can tobacco companies really reinvent themselves as healthcare companies?

A surprising move by key player, Phillip Morris, has called attention to the start of a new era for the tobacco industry. But can tobacco companies reinvent themselves as healthcare...

Why you should feel optimistic about the future of healthcare

It has been a difficult year to remain hopeful for those working in the healthcare industry, but there are some reasons to remain optimistic.